Mr Chris Nam
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
Eunwoo (Chris) Nam is a PhD candidate at the Centre for Cancer Biology, an alliance between Adelaide University and SA Pathology, in Adelaide, South Australia, Australia. For his PhD project, Chris works on investigating various ways to improve the efficacy of GD2 chimeric antigen receptor (CAR)-T cells against glioblastoma.
| Year | Citation |
|---|---|
| 2026 | Gardam, B., Gargett, T., Nam, E., Khan, S., Ormsby, R. J., Poonnoose, S. I., . . . Ebert, L. M. (2026). Tumors Located in the Brain Impair the Frequency and Phenotype of Dendritic Cells in Blood and Tumor.. iScience, 29(3), 115160. Scopus2 WoS2 Europe PMC1 |
| 2026 | Gardam, B., Nam, E., Kollis, P. M., Kilyen‐Coles, J., Lenin, S., Gliddon, B. L., . . . Gargett, T. (2026). A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. Clinical & Translational Immunology, 15(4), 19 pages. |
| 2024 | Lin, M. Y., Nam, E., Shih, R. M., Shafer, A., Bouren, A., Ceja, M. A., . . . Chen, Y. Y. (2024). Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy. Journal of Experimental Medicine, 221(6), 28 pages. Scopus36 WoS32 Europe PMC35 |
| 2020 | Zah, E., Nam, E., Bhuvan, V., Tran, U., Ji, B. Y., Gosliner, S. B., . . . Chen, Y. Y. (2020). Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma. Nature Communications, 11(1), 13 pages. Scopus199 WoS186 Europe PMC182 |
| 2017 | Li, S., Nih, L. R., Bachman, H., Fei, P., Li, Y., Nam, E., . . . Segura, T. (2017). Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability. Nature Materials, 16(9), 953-961. Scopus188 WoS175 Europe PMC150 |
Connect With Me
External Profiles
